Cancer

White Papers

How pharma can help the post-COVID recovery of European canc...

The new Cancer Care in Europe: Recovering from COVID-19 Disruption white paper assesses the disruption to patient care and the changes physicians i

R&D

Targeting COVID-19 and cancer with immunotherapy advancement...

Anna Biosciences’ Dr Anthony Rullo discusses the drug development company’s immunotherapy platform.

Views & Analysis

What HCPs think about health equity in cancer care

After more than a year of COVID-19 dominating health conversations, HCPs have been engaging in dialogue about continually evident disparities that many are facing in healthcare.

News

Elekta to work with academics on AI-directed radiotherapy

Radiotherapy specialist Elekta has joined forces with two academic groups in the Netherlands to explore the use of artificial intelligence (AI) to deliver more effective personalised therap

Views & Analysis

Health Innovators: Eliot Forster, F-Star

In this episode of Health Innovators, pharmaphorum founder Paul Tunnah interviews Eliot Forster, CEO of F-Star

Oncology

Close-up of East and Southeast Asia in the colorful world map.

Country focus: China & APAC’s growing medical needs bring op...

Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharma companies, and gives tips for companies navigating this enormous market.